| PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies BJ Chen, B Chapuy, J Ouyang, HH Sun, MGM Roemer, ML Xu, H Yu, ... Clinical Cancer Research 19 (13), 3462-3473, 2013 | 940 | 2013 |
| Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes MJ Malecki, C Sanchez-Irizarry, JL Mitchell, G Histen, ML Xu, JC Aster, ... Molecular and cellular biology, 2006 | 327 | 2006 |
| Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability C Ho, X Yao, L Tian, FY Li, N Podoltsev, ML Xu American journal of clinical pathology 141 (1), 62-71, 2014 | 133 | 2014 |
| Spatial profiling of chromatin accessibility in mouse and human tissues Y Deng, M Bartosovic, S Ma, D Zhang, P Kukanja, Y Xiao, G Su, Y Liu, ... Nature 609 (7926), 375-383, 2022 | 132 | 2022 |
| Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1 MY Chiang, ML Xu, G Histen, O Shestova, M Roy, Y Nam, SC Blacklow, ... Molecular and cellular biology 26 (16), 6261-6271, 2006 | 123 | 2006 |
| Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma M Hegde, SK Joseph, F Pashankar, C DeRenzo, K Sanber, S Navai, ... Nature communications 11 (1), 3549, 2020 | 116 | 2020 |
| Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved RM Shallis, RP Gale, HM Lazarus, KB Roberts, ML Xu, SE Seropian, ... Blood Reviews 47, 100773, 2021 | 84 | 2021 |
| Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL … L Deng, ZY Xu-Monette, S Loghavi, GC Manyam, Y Xia, C Visco, J Huh, ... Leukemia 30 (2), 361-372, 2016 | 81 | 2016 |
| A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies Y Song, A Rongvaux, A Taylor, T Jiang, T Tebaldi, K Balasubramanian, ... Nature communications 10 (1), 366, 2019 | 78 | 2019 |
| Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses N Romberg, C Le Coz, S Glauzy, JN Schickel, M Trofa, BE Nolan, ... Journal of Allergy and Clinical Immunology 143 (1), 258-265, 2019 | 73 | 2019 |
| MRI abnormalities of the hippocampus and cavum septi pellucidi in females with schizotypal personality disorder CC Dickey, RW McCarley, ML Xu, LJ Seidman, MM Voglmaier, ... Schizophrenia Research 89 (1-3), 49-58, 2007 | 70 | 2007 |
| Hippocampal atrophy in persons with age-associated memory impairment: volumetry within a common space MS Mega, GW Small, ML Xu, J Felix, M Manese, NP Tran, JI Dailey, ... Psychosomatic Medicine 64 (3), 487-492, 2002 | 68 | 2002 |
| Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer N Bar, F Costa, R Das, A Duffy, M Samur, S McCachren, SN Gettinger, ... JCI insight 5 (12), 2020 | 56 | 2020 |
| Sulcal variability in the Alzheimer's brain Correlations with cognition MS Mega, PM Thompson, JL Cummings, CL Back, ML Xu, S Zohoori, ... Neurology 50 (1), 145-151, 1998 | 54 | 1998 |
| High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq Y Liu, M DiStasio, G Su, H Asashima, A Enninful, X Qin, Y Deng, J Nam, ... Nature Biotechnology 41 (10), 1405-1409, 2023 | 51 | 2023 |
| Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms SS Patel, C Ho, RN Ptashkin, S Sadigh, A Bagg, JT Geyer, ML Xu, ... Blood Advances 3 (9), 1540-1545, 2019 | 51 | 2019 |
| Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience AK Ahmad, P Hui, B Litkouhi, M Azodi, T Rutherford, S McCarthy, MLQ Xu, ... International Journal of Gynecologic Cancer 24 (7), 2014 | 50 | 2014 |
| Microenvironment cell contribution to lymphoma immunity D Kumar, ML Xu Frontiers in oncology 8, 288, 2018 | 49 | 2018 |
| Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma–is it necessary? CY Ok, Q Ye, L Li, GC Manyam, L Deng, RR Goswami, X Wang, ... Oncotarget 6 (16), 13933, 2015 | 44 | 2015 |
| Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy JK Bailur, S Mehta, L Zhang, N Neparidze, T Parker, N Bar, T Anderson, ... Blood Advances 1 (25), 2343-2347, 2017 | 35 | 2017 |
